Exploring the relationship between sleep health and overall well-being

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study recruits participants to gather sleep and activity data using digital activity trackers. Participants will complete surveys on their baseline health and sleep characteristics, along with bi-weekly assessments of sleep quality and mood. The goal is to analyze how sleep impacts both physical and mental health among a large population of activity tracker users.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* Residing within the United States
* Ability to use the REFRESH app on the participant's own smartphone device

Exclusion Criteria:

* In-ability to consent

Where it's running

• Scripps Research Institute
  La Jolla, California, United States Recruiting

Study contacts

• Principal investigator: Stuti Jaiswal, MD, PhD — Scripps Research Institute
• Study coordinator: Stuti Jaiswal, MD, PhD
• Email: stuti@scripps.edu
• Phone: 858-784-2169

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• IBI362 for Chinese adults with obstructive sleep apnea and BMI ≥28

  This trial will see if once-weekly IBI362 injections help Chinese adults with moderate-to-severe obstructive sleep apnea who have a BMI of 28 or higher.

  Recruiting Phase 3 Innovent Biologics (Suzhou) Co. Ltd. · Beijing · NCT06931028

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

• Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists

  This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.

  Recruiting at 9 sites Phase 1 Amgen · Phoenix, Arizona and 8 other locations · NCT07908316

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.